Back to Journals » Risk Management and Healthcare Policy » Volume 13

Cancer Care Management During the COVID-19 Pandemic

Authors Jafari A, Rezaei-Tavirani M, Karami S, Yazdani M, Zali H, Jafari Z

Received 5 May 2020

Accepted for publication 2 September 2020

Published 23 September 2020 Volume 2020:13 Pages 1711—1721

DOI https://doi.org/10.2147/RMHP.S261357

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Marco Carotenuto


Ameneh Jafari,1,2 Mostafa Rezaei-Tavirani,1 Samira Karami,3 Mohsen Yazdani,4 Hakimeh Zali,1,5 Zahra Jafari6

1Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 3Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 4Department of Bioinformatics, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran; 5Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 6 9Dey Manzariye Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Correspondence: Hakimeh Zali Department of Tissue Engineering and Applied Sciences, School of Advanced Technologies in Medicine
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Tel +989123367156
Fax +982122439848
Email hakimehzali@gmail.com
Mostafa Rezaei-TaviraniProteomics Research Center, School of Allied Medical Sciences
Shahid Beheshti University of Medical Sciences, Tehran, Iran
Tel +982122439787
Email tavirany@yahoo.com

Abstract: New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are increasing around the world. Currently, health care services are mainly focused on responding to and controlling the unique challenges of the coronavirus disease 2019 (COVID-19) pandemic. These changes, along with the higher susceptibility of patients with cancer to infections, have profound effects on other critical aspects of care and pose a serious challenge for the treatment of such patients. During the COVID-19 pandemic, it is important to provide strategies for managing the treatment of patients with cancer to limit COVID-19-associated risks at this difficult time. The present study set out to summarize the latest research on epidemiology, pathogenesis, and clinical features of COVID-19. We also address some of the current challenges associated with the management of patients with cancer during the COVID-19 pandemic and provide practical guidance to clinically deal with these challenges.

Keywords: coronavirus, SARS-CoV-2, cancer, pandemic, health care

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]